Nalaganje...
A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers: A STROBE-compliant article
Recent breakthrough results from immune checkpoint inhibitors (ICIs) have paved the way to a new era of cancer immunotherapy, and have thus led to a paradigm shift of cancer treatment. In particular, inhibition of the antiprogrammed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis with ICI, inc...
Shranjeno v:
| izdano v: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8051980/ https://ncbi.nlm.nih.gov/pubmed/33847661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025494 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|